Kamada (KMDA) Change in Inventory (2012 - 2026)
Kamada's (KMDA) quarterly Change in Inventory came in at -$1.4 million in Q2 2026, up 61.35% on a YoY basis from -$891205.5 in Q2 2025, and down 191.09% quarter-over-quarter from -$494000.0 in Q1 2026.
Analysis
Kamada (KMDA) Change in Inventory (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Change in Inventory for 15 consecutive years, with -$1.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Inventory rose 61.35% year-over-year to -$1.4 million; the trailing twelve-month figure through Jun 2026 stood at -$4.8 million (down 42.48% YoY), and the FY2025 full-year result was -$6.1 million, down 163.4% from the prior year.
- Change in Inventory fell to -$1.4 million in Q2 2026 per KMDA's latest filing, from -$494000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $7.2 million in Q3 2024 and bottomed at -$14.7 million in Q4 2023.
- Historically, Change in Inventory has averaged -$1.1 million across 5 years, with a median of -$120500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory slumped 512.1% in 2023, then surged 1268.88% in 2024.
- Over 5 years, Change in Inventory stood at $4.2 million in 2022, then slumped by 445.89% to -$14.7 million in 2023, then soared by 50.55% to -$7.3 million in 2024, then surged by 106.46% to $469000.0 in 2025, then sank by 406.61% to -$1.4 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$1.4 million, -$494000.0, and $469000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Kamada | 473.57 Mn | 403.43 Mn | 22.47 Mn | -1.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.44 Mn |
| Mar 31, 2026 | -494,000.00 |
| Dec 31, 2025 | 469,000.00 |
| Sep 30, 2025 | -3.33 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Mar 31, 2025 | 461,000.00 |
| Dec 31, 2024 | -7.26 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | -14.68 Mn |
| Sep 30, 2023 | 6.44 Mn |
| Jun 30, 2023 | -482,000.00 |
| Mar 31, 2023 | -10.97 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Sep 30, 2022 | -8.51 Mn |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 2.66 Mn |
| Dec 31, 2021 | 3.59 Mn |
| Sep 30, 2021 | -3.56 Mn |